Babies exposed to PFAS “forever chemicals” in the womb have a higher risk of developing childhood asthma, a new study says. Very high prenatal exposure to PFAS appears to increase children’s risk of ...

A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, ...

Already known for their ties to immune system dysfunction, cancers and digestive issues, these findings add another notch to ...

PFAS, or per- and polyfluoroalkyl substances, are a group of human-made chemicals found in everything from food packaging to ...

There was a unidirectional causal relationship between childhood-onset asthma and the development of major mental health ...

A collaborative effort between researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and ...

GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick relief and daily control.

Scientists find that very high PFAS exposure before birth may increase asthma risk, highlighting hidden dangers in ...

Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight The severe asthma clinical trial analysis ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...

Allergy seasons are worsening nationwide, and a new report highlights the cities where pollen levels and symptoms are hitting ...